Bioprocessing Antibody Drug Conjugates in Biopharma: Making Magic Bullets

Article   Mar 28, 2017 | Original Article by Adam Tozer Ph.D

 
Bioprocessing Antibody Drug Conjugates in Biopharma: Making Magic Bullets

ADCs are the next generation of cancer therapies. Credit: Lonza

 
 
 
 

RELATED ARTICLES

Mass spectrometry: Bringing Precision and Clarity to Precision Medicine

Article

Mass spec systems are helping biomedical researchers gain deeper insight into the mechanisms of disease progression and therapeutic intervention, but the sheer volume and complexity of samples are challenging instrument makers to innovate.

READ MORE

Mass Spectrometry Workflow Solutions Top Lab Managers’ Wish Lists at ASMS 2017

Article

Streamlining workflows and easing lab manager “pain points” were common themes at this year’s annual meeting of the American Society of Mass Spectrometry (ASMS).

READ MORE

Metabolomics and Health – On the Cusp of a Revolution

Article

We ask leading experts about metabolomics potential to transform the future of healthcare.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE